93PD - Analysis of the androgen receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients.
Saved in:
| Title: | 93PD - Analysis of the androgen receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients. |
|---|---|
| Authors: | Del Re, M.1 (AUTHOR), Conteduca, V.2 (AUTHOR), Crucitta, S.3 (AUTHOR), Gurioli, G.2 (AUTHOR), Casadei, C.2 (AUTHOR), Restante, G.4 (AUTHOR), Schepisi, G.2 (AUTHOR), Lolli, C.2 (AUTHOR), Morganti, R.5 (AUTHOR), Danesi, R.6 (AUTHOR), De Giorgi, U.F.F.2 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement 6, Vol. 30, pv26-v26. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdz239.004 |
